Cargando…
Increased peritoneal permeability at peritoneal dialysis initiation is a potential cardiovascular risk in patients using biocompatible peritoneal dialysis solution
BACKGROUND: Cardiovascular disease is a frequent cause of death in peritoneal dialysis patients. Biocompatible peritoneal dialysis solutions with neutral pH have been anticipated to reduce cardiovascular disease more than conventional peritoneal dialysis solutions with low pH, but it remains unclear...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230909/ https://www.ncbi.nlm.nih.gov/pubmed/25361694 http://dx.doi.org/10.1186/1471-2369-15-173 |
_version_ | 1782344348205056000 |
---|---|
author | Hamasaki, Yoshifumi Doi, Kent Tanaka, Mototsugu Kume, Haruki Ishibashi, Yoshitaka Enomoto, Yutaka Fujita, Toshiro Homma, Yukio Nangaku, Masaomi Noiri, Eisei |
author_facet | Hamasaki, Yoshifumi Doi, Kent Tanaka, Mototsugu Kume, Haruki Ishibashi, Yoshitaka Enomoto, Yutaka Fujita, Toshiro Homma, Yukio Nangaku, Masaomi Noiri, Eisei |
author_sort | Hamasaki, Yoshifumi |
collection | PubMed |
description | BACKGROUND: Cardiovascular disease is a frequent cause of death in peritoneal dialysis patients. Biocompatible peritoneal dialysis solutions with neutral pH have been anticipated to reduce cardiovascular disease more than conventional peritoneal dialysis solutions with low pH, but it remains unclear which factors at peritoneal dialysis initiation increase cardiovascular risk in patients using biocompatible peritoneal dialysis solutions. This study was undertaken to investigate which clinical factors at peritoneal dialysis initiation, including peritoneal transport status, are associated with cardiovascular event in patients using biocompatible peritoneal dialysis solution. METHODS: This retrospective cohort study of peritoneal dialysis patients using biocompatible solutions with neutral pH assessed relations of clinical parameters at peritoneal dialysis initiation to cardiovascular event during the subsequent five years. RESULTS: Of 102 patients who started peritoneal dialysis, cardiovascular event occurred in 18. Age, history of cardiovascular disease before peritoneal dialysis initiation, hemoglobin, serum albumin, C-reactive protein, peritoneal permeability defined by the ratio of dialysate to plasma creatinine concentration at 4 hr (D/Pcre) in peritoneal equilibration test (PET), number of patients in each PET category defined by D/Pcre, and peritoneal protein clearance significantly differed between patients with and without cardiovascular event. For patients divided according to PET category using Kaplan–Meier method, the group of high average to high peritoneal transporters exhibited significantly high incidence of cardiovascular event and mortality compared with the groups of low and low-average peritoneal transporters (Log rank; p = 0.0003 and 0.005, respectively). A Cox proportional hazards model showed independent association of PET category classification with cardiovascular event. CONCLUSIONS: Peritoneal permeability expressed as PET category at peritoneal dialysis initiation is an independent cardiovascular risk factor in peritoneal dialysis patients using biocompatible peritoneal dialysis solution with neutral pH. Greater peritoneal permeability at peritoneal dialysis initiation might reflect subclinical vascular disorders. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2369-15-173) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4230909 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42309092014-11-14 Increased peritoneal permeability at peritoneal dialysis initiation is a potential cardiovascular risk in patients using biocompatible peritoneal dialysis solution Hamasaki, Yoshifumi Doi, Kent Tanaka, Mototsugu Kume, Haruki Ishibashi, Yoshitaka Enomoto, Yutaka Fujita, Toshiro Homma, Yukio Nangaku, Masaomi Noiri, Eisei BMC Nephrol Research Article BACKGROUND: Cardiovascular disease is a frequent cause of death in peritoneal dialysis patients. Biocompatible peritoneal dialysis solutions with neutral pH have been anticipated to reduce cardiovascular disease more than conventional peritoneal dialysis solutions with low pH, but it remains unclear which factors at peritoneal dialysis initiation increase cardiovascular risk in patients using biocompatible peritoneal dialysis solutions. This study was undertaken to investigate which clinical factors at peritoneal dialysis initiation, including peritoneal transport status, are associated with cardiovascular event in patients using biocompatible peritoneal dialysis solution. METHODS: This retrospective cohort study of peritoneal dialysis patients using biocompatible solutions with neutral pH assessed relations of clinical parameters at peritoneal dialysis initiation to cardiovascular event during the subsequent five years. RESULTS: Of 102 patients who started peritoneal dialysis, cardiovascular event occurred in 18. Age, history of cardiovascular disease before peritoneal dialysis initiation, hemoglobin, serum albumin, C-reactive protein, peritoneal permeability defined by the ratio of dialysate to plasma creatinine concentration at 4 hr (D/Pcre) in peritoneal equilibration test (PET), number of patients in each PET category defined by D/Pcre, and peritoneal protein clearance significantly differed between patients with and without cardiovascular event. For patients divided according to PET category using Kaplan–Meier method, the group of high average to high peritoneal transporters exhibited significantly high incidence of cardiovascular event and mortality compared with the groups of low and low-average peritoneal transporters (Log rank; p = 0.0003 and 0.005, respectively). A Cox proportional hazards model showed independent association of PET category classification with cardiovascular event. CONCLUSIONS: Peritoneal permeability expressed as PET category at peritoneal dialysis initiation is an independent cardiovascular risk factor in peritoneal dialysis patients using biocompatible peritoneal dialysis solution with neutral pH. Greater peritoneal permeability at peritoneal dialysis initiation might reflect subclinical vascular disorders. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2369-15-173) contains supplementary material, which is available to authorized users. BioMed Central 2014-11-01 /pmc/articles/PMC4230909/ /pubmed/25361694 http://dx.doi.org/10.1186/1471-2369-15-173 Text en © Hamasaki et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Hamasaki, Yoshifumi Doi, Kent Tanaka, Mototsugu Kume, Haruki Ishibashi, Yoshitaka Enomoto, Yutaka Fujita, Toshiro Homma, Yukio Nangaku, Masaomi Noiri, Eisei Increased peritoneal permeability at peritoneal dialysis initiation is a potential cardiovascular risk in patients using biocompatible peritoneal dialysis solution |
title | Increased peritoneal permeability at peritoneal dialysis initiation is a potential cardiovascular risk in patients using biocompatible peritoneal dialysis solution |
title_full | Increased peritoneal permeability at peritoneal dialysis initiation is a potential cardiovascular risk in patients using biocompatible peritoneal dialysis solution |
title_fullStr | Increased peritoneal permeability at peritoneal dialysis initiation is a potential cardiovascular risk in patients using biocompatible peritoneal dialysis solution |
title_full_unstemmed | Increased peritoneal permeability at peritoneal dialysis initiation is a potential cardiovascular risk in patients using biocompatible peritoneal dialysis solution |
title_short | Increased peritoneal permeability at peritoneal dialysis initiation is a potential cardiovascular risk in patients using biocompatible peritoneal dialysis solution |
title_sort | increased peritoneal permeability at peritoneal dialysis initiation is a potential cardiovascular risk in patients using biocompatible peritoneal dialysis solution |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230909/ https://www.ncbi.nlm.nih.gov/pubmed/25361694 http://dx.doi.org/10.1186/1471-2369-15-173 |
work_keys_str_mv | AT hamasakiyoshifumi increasedperitonealpermeabilityatperitonealdialysisinitiationisapotentialcardiovascularriskinpatientsusingbiocompatibleperitonealdialysissolution AT doikent increasedperitonealpermeabilityatperitonealdialysisinitiationisapotentialcardiovascularriskinpatientsusingbiocompatibleperitonealdialysissolution AT tanakamototsugu increasedperitonealpermeabilityatperitonealdialysisinitiationisapotentialcardiovascularriskinpatientsusingbiocompatibleperitonealdialysissolution AT kumeharuki increasedperitonealpermeabilityatperitonealdialysisinitiationisapotentialcardiovascularriskinpatientsusingbiocompatibleperitonealdialysissolution AT ishibashiyoshitaka increasedperitonealpermeabilityatperitonealdialysisinitiationisapotentialcardiovascularriskinpatientsusingbiocompatibleperitonealdialysissolution AT enomotoyutaka increasedperitonealpermeabilityatperitonealdialysisinitiationisapotentialcardiovascularriskinpatientsusingbiocompatibleperitonealdialysissolution AT fujitatoshiro increasedperitonealpermeabilityatperitonealdialysisinitiationisapotentialcardiovascularriskinpatientsusingbiocompatibleperitonealdialysissolution AT hommayukio increasedperitonealpermeabilityatperitonealdialysisinitiationisapotentialcardiovascularriskinpatientsusingbiocompatibleperitonealdialysissolution AT nangakumasaomi increasedperitonealpermeabilityatperitonealdialysisinitiationisapotentialcardiovascularriskinpatientsusingbiocompatibleperitonealdialysissolution AT noirieisei increasedperitonealpermeabilityatperitonealdialysisinitiationisapotentialcardiovascularriskinpatientsusingbiocompatibleperitonealdialysissolution |